PI
CVS icon

PEAK6 Investments’s CVS Health CVS Stock Holding History

PEAK6 Investments’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$635K Sell
10,100
-52,300
-84% -$3.05M ﹤0.01% 2181
2024
Q2 		$3.69M Buy
62,400
+44,700
+253% +$2.8M 0.01% 1009
2024
Q1 		$1.41M Sell
17,700
-13,300
-43% -$1.02M ﹤0.01% 1682
2023
Q4 		$2.45M Sell
31,000
-11,500
-27% -$818K 0.01% 1354
2023
Q3 		$2.97M Sell
42,500
-12,400
-23% -$879K 0.01% 1058
2023
Q2 		$3.8M Sell
54,900
-73,100
-57% -$5.2M 0.02% 798
2023
Q1 		$9.51M Buy
128,000
+126,400
+7,900% +$10.6M 0.05% 410
2022
Q4 		$149K Sell
1,600
-51,300
-97% -$4.95M ﹤0.01% 3456
2022
Q3 		$5.04M Sell
52,900
-16,200
-23% -$1.6M 0.02% 827
2022
Q2 		$5.11M Sell
69,100
-75,400
-52% -$7.36M 0.01% 1360
2022
Q1 		$14.6M Sell
144,500
-596,200
-80% -$62.6M 0.03% 537
2021
Q4 		$76.4M Buy
740,700
+523,700
+241% +$48.4M 0.16% 108
2021
Q3 		$18.4M Sell
217,000
-239,544
-52% -$20.1M 0.04% 423
2021
Q2 		$38.5M Buy
456,544
+174,144
+62% +$14.3M 0.09% 196
2021
Q1 		$21.2M Sell
282,400
-187,600
-40% -$13.7M 0.05% 331
2020
Q4 		$32.1M Buy
470,000
+132,600
+39% +$8.62M 0.07% 259
2020
Q3 		$19.7M Buy
337,400
+148,600
+79% +$9.25M 0.05% 338
2020
Q2 		$12.3M Sell
188,800
-52,700
-22% -$3.32M 0.04% 412
2020
Q1 		$14.3M Buy
241,500
+73,400
+44% +$4.9M 0.08% 232
2019
Q4 		$12.5M Buy
168,100
+49,500
+42% +$3.48M 0.06% 316
2019
Q3 		$7.42M Buy
118,600
+78,400
+195% +$4.65M 0.05% 491
2019
Q2 		$2.19M Sell
40,200
-20,700
-34% -$1.11M 0.01% 1222
2019
Q1 		$3.28M Buy
60,900
+8,400
+16% +$518K 0.02% 956
2018
Q4 		$3.44M Buy
52,500
+20,100
+62% +$1.5M 0.02% 871
2018
Q3 		$2.55M Buy
+32,400
New +$2.32M 0.01% 1255

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

PEAK6 Investments's CVS Position: Q3 2024 in Review

PEAK6 Investments increased its CVS Health (CVS) stake by 255% in Q3 2024, buying an estimated $12.3M and bringing the position to 292,920 shares worth $18.4M. The position accounts for 0.04% of the portfolio, ranked #360.

PEAK6 Investments first reported a position in CVS in Q4 2018 and has held it in 17 quarters since. The position peaked at $41.1M in Q1 2019. 1,841 funds tracked by Wall St. Rank hold CVS as of Q3 2024.

  • PEAK6 Investments held 292,920 shares of CVS Health worth $18.4M as of Q3 2024.
  • PEAK6 Investments bought 210,350 CVS Health shares in Q3 2024, an estimated $12.3M.
  • CVS Health made up 0.04% of PEAK6 Investments's portfolio in Q3 2024, its #360 holding.
  • PEAK6 Investments first reported a position in CVS Health in Q4 2018 and has held it in 17 quarters since.
  • PEAK6 Investments's CVS Health position peaked at $41.1M in Q1 2019.
  • 1,841 funds tracked by Wall St. Rank held CVS Health as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.